An Aspira catheter is a tunneled indwelling catheter placed through a small incision to drain fluid that keeps building up in the chest (pleural effusion) or abdomen (ascites), most often because of cancer. The procedure is minimally invasive, typically done under local anesthesia on an outpatient basis, and allows you to drain fluid at home rather than returning to the hospital for repeated needle procedures. While the Aspira is one of two major catheter brands used for this purpose, the placement technique and clinical outcomes are broadly similar across tunneled catheter systems, and much of the research on these devices applies to both.
Why Tunneled Catheters Are Placed
The most common reason for an Aspira catheter is a malignant pleural effusion, which is fluid accumulating in the space between the lung and the chest wall due to cancer. Lung cancer, breast cancer, and lymphoma are frequent culprits, but almost any cancer that spreads to the chest lining can cause this problem. The fluid compresses the lung, producing shortness of breath that worsens as the effusion grows. Without treatment, the fluid returns within days to weeks after a simple drainage procedure, leaving patients stuck in a cycle of emergency visits and repeated needle taps.1BMJ Open Respiratory Research. Management of malignant pleural effusions using an indwelling tunnelled pleural catheter and non-vacuum collection system
Tunneled catheters are also placed in the abdomen for malignant ascites, the buildup of fluid in the peritoneal cavity caused by cancers such as ovarian, pancreatic, or gastrointestinal malignancies. In a study of patients receiving the second-generation Aspira peritoneal catheter, eligibility generally required at least two drainage procedures per month before placement was considered, and patients with very short expected survival (under three weeks) were typically excluded.2CVIR Oncology. Clinical outcomes following insertion of second-generation (Aspira®) tunneled indwelling peritoneal catheters to treat malignant ascites Refractory ascites from liver disease is another indication. In those cases, a tunneled peritoneal catheter serves as an alternative to a TIPS procedure (a shunt placed through the liver) when TIPS is not feasible or contraindicated.3PubMed Central. Comparison of clinical outcomes in patients with refractory ascites treated with either TIPS, tunneled peritoneal catheter, or ascites pump
Tunneled pleural catheters have a particular advantage in patients with “trapped lung,” where the lung cannot fully re-expand because scar tissue or tumor coats its surface. In that situation, chemical pleurodesis (sealing the pleural space shut with talc or another agent) does not work because the lung cannot meet the chest wall. A tunneled catheter bypasses the problem entirely by draining fluid on an ongoing basis rather than trying to prevent it from forming.4PubMed. Management of malignant pleural effusions
How the Procedure Works
Placement of a tunneled catheter is typically performed by an interventional radiologist or a pulmonologist, though thoracic surgeons and some medical oncologists also place them. The procedure usually takes about 30 to 45 minutes and can be done on an outpatient basis under local anesthesia, meaning you are awake but the area is numbed.5PubMed Central. Indwelling pleural catheters: complications and management strategies
Two small incisions are made, roughly five centimeters apart. One incision is at the point where the catheter will enter the chest (or abdominal) cavity, and the other is at the exit site where the external portion of the catheter will emerge through the skin. The catheter is threaded through a tunnel under the skin between these two points. Midway along this tunnel sits a polyester cuff that gradually bonds with the surrounding tissue over a few weeks. This cuff serves two purposes: it anchors the catheter in place so it does not migrate, and it creates a physical barrier that helps block bacteria from tracking along the catheter into the body.6Tuberculosis and Respiratory Diseases. Chest Tube Drainage of the Pleural Space: A Concise Review for Pulmonologists
To get the catheter into the pleural or peritoneal space, doctors use what is called the Seldinger technique: a needle is inserted under imaging guidance, a thin wire is passed through the needle, and the needle is removed, leaving the wire as a guide. A dilator is slid over the wire to widen the tract, and the fenestrated (perforated) end of the catheter is advanced into the fluid-filled cavity. The external end of the catheter has a one-way valve that allows fluid and air to flow out but prevents anything from entering when the catheter is not connected to a drainage system.7Tuberculosis and Respiratory Diseases. Chest Tube Drainage of the Pleural Space: A Concise Review for Pulmonologists
What Imaging Is Used During Placement
Ultrasound is the standard imaging tool for guiding catheter placement. It lets the operator visualize the fluid pocket in real time, confirm the safest entry point, and avoid puncturing the lung, diaphragm, or major blood vessels. Some centers add fluoroscopy (live X-ray) as an additional guide, and there is evidence this combination can reduce the need for a second procedure afterward.
A retrospective study comparing ultrasound alone to ultrasound plus fluoroscopy for draining difficult, loculated pleural effusions found that the combined approach cut the reintervention rate roughly in half. About a third of patients guided by ultrasound alone needed a follow-up procedure, compared with under a fifth of those who had both imaging modalities. After adjusting for patient differences, the odds of needing reintervention were about 60% lower with the combined approach.8PubMed Central. Ultrasound-Fluoroscopy Versus Ultrasound Guidance for Catheter Drainage of Loculated Pleural Effusions: A Retrospective Study For straightforward, free-flowing effusions, ultrasound alone is usually sufficient. Fluoroscopy becomes more valuable when the fluid is divided into separate pockets by adhesions or when the anatomy is tricky.
Aspira Versus PleurX
The two main brands of tunneled indwelling pleural catheter on the market are the Aspira (made by Becton Dickinson, formerly Bard) and the PleurX (made by BD/CareFusion). They use the same basic design: a silicone tube with a polyester cuff and a one-way valve. The practical difference is in the external drainage system. The Aspira uses a gravity-based drainage bag, while the PleurX uses vacuum bottles that apply suction to pull fluid out.
For patients and clinicians wondering whether one is meaningfully better than the other, the available evidence suggests they perform about the same. A study directly comparing the two catheter types in patients with malignant pleural effusions found that symptom relief was achieved in all patients regardless of which catheter they received. The complication rate was about 39% in the Aspira group and 33% in the PleurX group, a difference that was not statistically significant. Spontaneous pleurodesis (the pleural surfaces scarring together so the catheter can eventually be removed) occurred at similar rates in both groups.9PubMed Central. A comparison between two types of indwelling pleural catheters for management of malignant pleural effusions10Journal of Clinical Oncology. Comparison of two indwelling pleural catheter types for malignant pleural effusions
The choice between the two often comes down to institutional preference, supply contracts, and which drainage system the patient finds easier to manage at home. The Aspira’s gravity bags are quieter and do not require disposable vacuum bottles, which some patients find less intimidating. The PleurX vacuum bottles can apply more consistent suction, which some practitioners prefer for viscous or protein-rich effusions. In practice, the brand matters less than having good patient education and reliable follow-up care.
Tunneled Catheters Compared to Talc Pleurodesis
For patients with malignant pleural effusions who do not have trapped lung, the main alternative to a tunneled catheter is talc pleurodesis: talc is instilled into the pleural space (either through a chest tube at the bedside or during a thoracoscopic procedure) to irritate the pleural surfaces and cause them to fuse, eliminating the space where fluid collects. Both approaches relieve breathlessness effectively, and neither one clearly wins on survival.
Where they differ is in the trade-offs. Tunneled catheters require significantly less time in the hospital. The landmark TIME2 trial found a median initial hospitalization of zero days for the catheter group compared to four days for the talc group.11JAMA. Effect of an Indwelling Pleural Catheter vs Chest Tube and Talc Pleurodesis for Relieving Dyspnea in Patients With Malignant Pleural Effusion: The TIME2 Randomized Controlled Trial A meta-analysis of randomized trials confirmed that total hospital days and repeat pleural procedures were both lower in the catheter group.12Annals of the American Thoracic Society. Indwelling Pleural Catheter versus Pleurodesis for Malignant Pleural Effusions. A Systematic Review and Meta-Analysis
On the other hand, talc pleurodesis achieves higher rates of permanent pleurodesis (eliminating the effusion for good), and a meta-analysis of randomized trials found that the pleurodesis group had fewer overall complications, including less catheter blockage and cellulitis.13PubMed Central. Talc pleurodesis versus indwelling pleural catheter among patients with malignant pleural effusion: a meta-analysis of randomized controlled trials The systematic review found that the risk of cellulitis (skin infection around the catheter site) was nearly six times higher with an indwelling catheter than with pleurodesis.14Annals of the American Thoracic Society. Indwelling Pleural Catheter versus Pleurodesis for Malignant Pleural Effusions. A Systematic Review and Meta-Analysis So the decision often comes down to priorities: if minimizing hospital time is paramount and the patient can manage drainage at home, a tunneled catheter is attractive. If the goal is a one-and-done solution and the patient can tolerate a hospital stay, pleurodesis may be preferred.
Complications and How Often They Happen
Tunneled catheter placement is generally safe, but complications are not rare. In the head-to-head comparison study, the overall complication rate across both the Aspira and PleurX groups was about 37%, which included pain, catheter obstruction, loculations, infection, and hemorrhage.15PubMed Central. A comparison between two types of indwelling pleural catheters for management of malignant pleural effusions Most of these were manageable and did not require catheter removal.
Infection is the complication that gets the most attention. In malignant pleural effusions, pleural infection rates with tunneled catheters are relatively low, typically in the range of a few percent. The picture can be different in other patient populations: in a series of patients who received indwelling pleural catheters for hepatic hydrothorax (fluid from liver disease leaking into the chest), complications occurred in about 36% of patients, and empyema (infected fluid in the pleural space) was the most common, diagnosed in roughly one in six patients.16PubMed Central. Indwelling Pleural Catheters in Hepatic Hydrothorax: A Single-Center Series of Outcomes and Complications This higher infection rate in liver patients is thought to relate to immune dysfunction associated with advanced liver disease, making careful patient selection especially important in that group.
Catheter blockage is another common issue. The fenestrations at the catheter tip can become occluded by fibrin, blood clots, or tumor debris, causing the catheter to stop draining. When this happens, instilling a fibrinolytic agent (a clot-dissolving drug) through the catheter can sometimes restore flow. A case report documented successful drainage of a complex loculated malignant effusion using just one milligram of alteplase instilled through a non-draining catheter, which is notably a very low dose.17BMJ Case Reports. Successful treatment of a complex malignant pleural effusion with 1 mg alteplase instilled through a non-draining indwelling pleural catheter Your medical team will decide the approach if this happens, but blockage is generally a fixable problem rather than one requiring catheter replacement.
Pain During and After the Procedure
Because tunneled catheters use a relatively small-bore tube (typically 15.5 French, roughly the diameter of a pen refill), the insertion is less painful than placement of a large surgical chest tube. Tube diameter matters: larger bore tubes require blunt dissection through the chest wall, while smaller tubes can be placed percutaneously with the Seldinger technique, producing less tissue trauma.18PubMed Central. Periprocedural pain management in pleural disease: a narrative review of current and emerging strategies
Standard practice is to numb the area with lidocaine before the procedure begins. Some centers also give a low dose of intravenous sedation or an oral opioid beforehand for comfort. The British Thoracic Society guidelines recommend initiating analgesia before any percutaneous chest tube placement, suggesting either intravenous or oral morphine alongside local anesthesia.19PubMed Central. Periprocedural pain management in pleural disease: a narrative review of current and emerging strategies
Post-procedure pain is usually mild and manageable with over-the-counter analgesics, though some discomfort around the tunnel site and the exit wound can persist for a few days as the tissue heals. The evidence on intrapleural pain control after chest drain insertion is surprisingly thin. One small study found that adding dexmedetomidine to bupivacaine instilled through a chest tube extended effective pain relief to over seven hours on average, compared to less than an hour for saline alone, but these results come from a trial of just 28 patients and have not been widely replicated.20PubMed Central. Periprocedural pain management in pleural disease: a narrative review of current and emerging strategies In practice, most patients report that the placement is far more tolerable than they anticipated.
Living with the Catheter at Home
One of the main advantages of a tunneled catheter is that it shifts fluid management from the hospital to the home. After placement, most patients or their caregivers are trained to connect a drainage bag or vacuum bottle to the catheter, open the valve, drain fluid for about 10 to 15 minutes (or until flow stops), and then close the valve and disconnect. Drainage frequency varies by patient: some drain daily, while others need to do it only two or three times a week depending on how fast fluid reaccumulates.
Keeping the exit site clean and dry is the single most important thing you can do to prevent infection. The site should be covered with a clean dressing, changed regularly, and inspected for redness, swelling, warmth, or discharge. Showering is usually permitted with waterproof dressings, but submerging the site in bath water or swimming pools is generally discouraged until the cuff has fully incorporated, which takes a few weeks.
There is an often-overlooked upside to tunneled catheters: the possibility of spontaneous pleurodesis. In up to half of patients with malignant pleural effusions, regular drainage through the catheter causes the pleural surfaces to gradually stick together, eliminating the space where fluid collects. When drainage output drops consistently to very small volumes, imaging can confirm that the effusion has resolved, and the catheter can then be removed.21PubMed. Management of malignant pleural effusions Getting free of the catheter is a meaningful quality-of-life milestone for patients, and it happens more often than many expect at the time of placement.
Cost Considerations
Cost-effectiveness depends heavily on how long a patient is expected to survive, which is a difficult but necessary conversation in the palliative setting. A modeling study found that for patients with an expected survival of about three months, a tunneled pleural catheter was less expensive and more effective than both forms of pleurodesis. The estimated cost of catheter treatment was about $6,450, compared with roughly $11,200 for bedside pleurodesis and over $18,600 for thoracoscopic pleurodesis. However, for patients expected to survive around 12 months, bedside pleurodesis became the least expensive option at about $13,000, edging out the catheter at roughly $13,200, because the ongoing cost of drainage supplies accumulates over time.22PubMed Central. Treatment of Malignant Pleural Effusion: A Cost-Effectiveness Analysis
The takeaway is that tunneled catheters tend to be the better economic choice for patients with shorter expected survival, while pleurodesis may be more cost-effective for patients likely to live longer. Repeated thoracentesis (needle drainage without a permanent catheter) was the cheapest upfront option in the model but delivered the fewest quality-adjusted benefits, mostly because of the burden of repeated hospital visits.23PubMed Central. Treatment of Malignant Pleural Effusion: A Cost-Effectiveness Analysis
The Emotional Side of Living with a Catheter
Having a tube protruding from your chest or abdomen for weeks or months carries a psychological weight that clinical outcome studies tend to undercount. A qualitative study exploring the psychosocial impact of living with an indwelling pleural catheter identified several recurring themes: anxiety about the device, changes in daily activities, effects on relationships, and a sense of shifting independence and control. These experiences were not static. Many patients initially felt anxious or self-conscious but gradually moved toward acceptance and even confidence as they became more skilled at managing the drainage routine.24BMJ Open Respiratory Research. Psychosocial impact of living with an indwelling pleural catheter in patients with malignant pleural effusions: a thematic analysis
The study also found that positive and negative psychological effects coexisted. On the positive side, being able to drain at home and avoid hospital trips gave patients a sense of autonomy that they valued. On the negative side, the physical presence of the catheter served as a constant reminder of the underlying cancer, and dependence on a caregiver for drainage could strain relationships. These findings reinforce something that clinical data on complication rates and hospital days can miss: the quality of patient education and the availability of emotional support make a real difference in how well someone copes with a tunneled catheter.
Peritoneal Catheters for Ascites
While much of the literature on tunneled catheters focuses on pleural effusions, the same technology is increasingly used for malignant ascites. The Aspira catheter has a peritoneal version designed specifically for abdominal placement. A retrospective study of patients who received the second-generation Aspira peritoneal catheter for malignant ascites found that the devices were associated with a tolerable safety profile and provided meaningful improvement in quality of life.25CVIR Oncology. Clinical outcomes following insertion of second-generation (Aspira®) tunneled indwelling peritoneal catheters to treat malignant ascites
For patients with refractory ascites from liver disease rather than cancer, the tunneled peritoneal catheter competes with other low-flow devices like the automated ascites pump, which continuously moves small volumes of fluid from the abdomen into the bladder for excretion. Both approaches achieve symptom control, and the choice between them depends on the patient’s anatomy, candidacy for surgery, and preference for self-managed drainage versus an implanted device.26PubMed Central. Comparison of clinical outcomes in patients with refractory ascites treated with either TIPS, tunneled peritoneal catheter, or ascites pump One important caveat: infection risk in liver patients tends to be higher than in cancer patients, so the decision to place a peritoneal catheter in someone with cirrhosis warrants careful discussion with the hepatology team.